Integrated Core Strategies (US) LLC holds 5.3% of Fortress Biotech, equal to 1,778,133 common shares. The holder certified that the position was not acquired or maintained to change or influence Fortress Biotech’s control, giving investors a defined passive-ownership status rather than an expressly stated control objective.

Key Highlights

  • Fortress Biotech common stock carries a Par Value of $0.001 per share.
  • The joint filing agreement among the reporting parties is dated August 31, 2026.
  • Integrated Core Strategies (US) LLC reports a 5.3% ownership position in Fortress Biotech, representing 1,778,133 common shares.

Fortress Biotech, Inc. (NASDAQ: FBIO) has a reported 5.3% ownership position held by Integrated Core Strategies (US) LLC, representing 1,778,133 common shares. The position is reported through a Schedule 13G under Rule 13d-1(c). The certification states that the securities were not acquired or held to change or influence control of Fortress Biotech.

Millennium Entities Listed

The filing says the reported information should not, by itself, be treated as an admission of beneficial ownership by those parties of securities held by the entities. Fortress Biotech’s reported security is common stock with a par value of $0.001 per share.

Passive Investment Intent

The reporting parties certified that the securities were not acquired or held for the purpose of changing or influencing Fortress Biotech’s control. The ownership disclosure therefore identifies a passive position rather than an expressly stated control objective.

Joint Agreement Dated August 31

The reporting parties entered into a Joint Filing Agreement dated August 31, 2026. The agreement authorizes the Schedule 13G to be submitted on behalf of each named person and entity. Integrated Core Strategies (US) LLC is shown c/o Millennium Management LLC at that address.